Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
Bio-Reference Labs, Inc. (NQ: BRLI)
28.69 USD  +0.08 (+0.28%)
Streaming Delayed Price  /  Updated: 2:14 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Bio-Reference Labs, Inc.
 
< Previous 1 2 3 4 5 Next >
GeneDx to Launch Comprehensive Breast Cancer Genetic Test
June 13, 2013
from PR Newswire
Biotech Services Take Advantage of Technological Revolution through Innovations - Research Report on Life Technologies, PerkinElmer, PAREXEL, Genomic Health, and Bio-Reference
June 07, 2013
from PR Newswire
UPDATE -- BioReference Laboratories, Inc. Reports Record Quarterly Results Based on Sustained Growth
June 06, 2013
Quarterly Revenues Highest in Corporate History Read More
from GlobeNewswire News Releases
BioReference Laboratories, Inc. Reports Record Quarterly Results Based on Sustained Growth
June 06, 2013
Quarterly Revenues and Earnings Highest in Corporate History Read More
from GlobeNewswire News Releases
Bio-Reference Laboratories, Inc to Speak at William Blair & Company's 33rd Annual Growth Stock Conference
June 05, 2013
from GlobeNewswire News Releases
Bio-Reference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2013
May 30, 2013
from GlobeNewswire News Releases
BioReference Laboratories, Inc to Speak at the UBS Global Healthcare Conference
May 15, 2013
from GlobeNewswire News Releases
Bio-Reference Laboratories, Inc. to Speak at the Bank of America Merrill Lynch Health Care Conference
May 08, 2013
from GlobeNewswire News Releases
Bio-Reference Laboratories, Inc. Responds to an Employee Wrongful Termination Suit Filed Against it as Baseless and Without Merit
April 12, 2013
from GlobeNewswire News Releases
Bio-Reference Laboratories, Inc. Announces Strong Growth Resulting in Record First Quarter Revenue and Earnings
February 28, 2013
Q1FY13 Results Reported in Accordance With Update 954 Reclassifications Read More
from GlobeNewswire News Releases
Bio-Reference Laboratories, Inc. Will Offer Non-Invasive Prenatal Testing (NIPT) From Natera
February 27, 2013
from GlobeNewswire News Releases
Bio-Reference Laboratories, Inc. Announces Earnings Will be Reported on February 28, 2013, Will Reflect Change in Presentation of Revenues and Bad Debt to Comply With Accounting Standards Update Topic
February 25, 2013
Company Reaffirms Guidance for the Fiscal Year 2013 Read More
from GlobeNewswire News Releases
BetterInvesting Magazine Releases April Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use
February 01, 2013
from PR Newswire
Should Recent Insider Selling on CMI, XL, RYN and BRLI Matter to You?
December 20, 2012
from Marketwired News Releases
Bergen County-based Bio-Reference Donates $100,000 to Hurricane Sandy New Jersey Relief Fund
December 18, 2012
Cites Devastation Particularly in Bergen County as Impetus for Contribution Read More
from PR Newswire
Free Research Reports on AKAM, BRLI, TD and ZNGA Issued by the Bedford Report
December 07, 2012
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Bio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and for Full Fiscal Year Despite Effects of Hurricane Sandy
December 06, 2012
from Business Wire News Releases
BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2012
December 05, 2012
from Business Wire News Releases
BetterInvesting Magazine Releases February Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use
November 30, 2012
from PR Newswire
Bio-Reference to Launch Laboratorio Buena Salud, The First Nationwide Full-Service Hispanic Laboratory
October 10, 2012
Laboratorio Buena Salud Will Serve the Hispanic community Across the U.S. Read More
from PR Newswire
IncellDx, Inc. Announces an Agreement with BioReference Laboratories, Inc. to Conduct a 10,000 Sample Study Using a Slideless Pap Smear
September 12, 2012
Incell3Dx™ technology could revolutionize the $5 Billion Pap smear industry Read More
from PR Newswire
Bio-Reference Laboratories, Inc. Reports Best Quarterly Revenues and Earnings in Corporate History with 25% Increase in Earnings Per Share
August 30, 2012
from Business Wire News Releases
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter Fiscal Year 2012
August 23, 2012
from Business Wire News Releases
CareEvolve and ZoomMed USA Will Offer Integrated e-Prescribing to 30,000 Physicians
August 02, 2012
from Marketwired News Releases
CareEvolve et ZoomMed USA offrent conjointement un prescripteur électronique à 30 000 médecins
August 02, 2012
from Marketwired
CareEvolve and ZoomMed USA Will Offer Integrated e-Prescribing to 30,000 Physicians
August 01, 2012
from Business Wire News Releases
GenPath Diagnostics of BioReference Laboratories, Inc. Awarded 2012 Clinical Diagnostics Company of the Year Award by Frost & Sullivan
June 26, 2012
from Business Wire News Releases
Bio-Reference Laboratories, Inc. Reports Strong Quarterly Results
June 07, 2012
from Business Wire News Releases
BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter Fiscal Year 2012
May 31, 2012
from Business Wire News Releases
BRLI Announces InCellDx Investment and Launch of GenCerv Test Through its GenPath Women’s Health Laboratory
April 30, 2012
from Business Wire News Releases
< Previous 1 2 3 4 5 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here